Published in Physician Law Weekly, October 12th, 2005
Net sales increased 11% to $484,903,000. Operating income increased 41% to $151,410,000 from $107,232,000 and increased 8%, on an adjusted basis, from $140,254,000. Net income increased 66% to $100,299,000 from $60,433,000 and increased 10%, as adjusted, from $91,023,000. Diluted earnings per share increased 67% to $0.40 from $0.24 and increased 11%, on an adjusted basis, from $0.36.
The company's 2004 reported results reflect the acquisition of Merck KGaA's interest in the Biomet Merck joint venture on March 19, 2004, as well as the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly